Brain/CNS Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Brain/CNS
| Protocol | Alliance A072301 |
|---|---|
| Cancer Type: | Brain |
| Fast Facts |
Protocol A072301: Phase III trial of radiotherapy followed by adjuvant temozolomide in combination with the IDH inhibitor vorasidenib vs. placebo in IDH-mutated newly-diagnosed grade 3 astrocytomas.
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG BN003 |
|---|---|
| Cancer Type: | MENINGIOMA |
| Fast Facts |
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
